{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:52:39Z","timestamp":1791996759745,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2024JJ4078"],"award-info":[{"award-number":["2024JJ4078"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ40832"],"award-info":[{"award-number":["2023JJ40832"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011790","name":"Xiangya Hospital, Central South University","doi-asserted-by":"publisher","award":["7933"],"award-info":[{"award-number":["7933"]}],"id":[{"id":"10.13039\/501100011790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473534"],"award-info":[{"award-number":["82473534"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82504286"],"award-info":[{"award-number":["82504286"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.intimp.2026.116936","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T23:55:09Z","timestamp":1780358109000},"page":"116936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pharmacological inhibition of TXNRD1 attenuates psoriasis-like dermatitis by suppressing keratinocyte proliferation and NF-\u03baB signaling"],"prefix":"10.1016","volume":"184","author":[{"given":"Xiao","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanshan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.116936_bb0005","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.intimp.2026.116936_bb0010","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s40257-024-00887-8","article-title":"Predicting the time to relapse following withdrawal from different biologics in patients with psoriasis who responded to therapy: A 12-year multicenter cohort study","volume":"25","author":"Huang","year":"2024","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.intimp.2026.116936_bb0015","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","article-title":"Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis","volume":"397","author":"Ghoreschi","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2026.116936_bb0020","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.jid.2024.07.040","article-title":"The Role of Crosstalk between Nets and Keratinocytes in Skin Immunity","volume":"145","author":"Zhou","year":"2025","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2026.116936_bb0025","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/jdv.14433","article-title":"The role of IL.tigative Dermatologyand Keratinocytes in Skin Immnesis and treatment of psoriasis","volume":"31","author":"Girolomoni","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.intimp.2026.116936_bb0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.21767\/2471-8513.100057","article-title":"Autoimmune mechanisms of psoriasis: pathogenic role of the IL-23\/IL-17 axis","volume":"4","author":"Wolf","year":"2018","journal-title":"J Autoimmune Disord"},{"key":"10.1016\/j.intimp.2026.116936_bb0035","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3389\/fimmu.2018.01549","article-title":"The interplay between keratinocytes and immune cells in the pathogenesis of psoriasis","volume":"9","author":"Albanesi","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116936_bb0040","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2174\/1568010054022033","article-title":"Keratinocytes in inflammatory skin diseases","volume":"4","author":"Albanesi","year":"2005","journal-title":"Current Drug Targets-Inflammation & Allergy"},{"key":"10.1016\/j.intimp.2026.116936_bb0045","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jdermsci.2011.11.007","article-title":"Chemokine receptors in the pathogenesis and therapy of psoriasis","volume":"65","author":"Mabuchi","year":"2012","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.intimp.2026.116936_bb0050","series-title":"Selenium","first-page":"111","author":"Ingold","year":"2018"},{"key":"10.1016\/j.intimp.2026.116936_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24183333","article-title":"The thioredoxin system is regulated by the ASK-1\/JNK\/p38\/survivin pathway during germ cell apoptosis","volume":"24","author":"Al-Kandari","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2026.116936_bb0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/ars.2007.9.25","article-title":"Thioredoxin and related molecules\u2013from biology to health and disease","volume":"9","author":"Lillig","year":"2007","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.intimp.2026.116936_bb0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s43587-023-00564-1","article-title":"TXNRD1 drives the innate immune response in senescent cells with implications for age-associated inflammation","volume":"4","author":"Hao","year":"2024","journal-title":"Nature aging"},{"key":"10.1016\/j.intimp.2026.116936_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27011","article-title":"Txnrd1 as a prognosticator for recurrence, metastasis and response to neoadjuvant chemotherapy and radiotherapy in breast cancer patients","volume":"10","author":"Patwardhan","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.intimp.2026.116936_bb0075","first-page":"S97","article-title":"Role of thioredoxin system in regulating cellular redox status in Alzheimer\u2019s disease","volume":"99","author":"Qaiser","year":"2024","journal-title":"J. Alzheimer's Dis"},{"key":"10.1016\/j.intimp.2026.116936_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103245","article-title":"The rheumatoid arthritis drug auranofin exerts potent anti-lymphoma effect by stimulating TXNRD-mediated ROS generation and inhibition of energy metabolism","volume":"75","author":"Yang","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.intimp.2026.116936_bb0085","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf7444","article-title":"Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy","volume":"10","author":"Stafford","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2026.116936_bb0090","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/jid.2010.340","article-title":"Integrative responses to IL-17 and TNF-\u03b1 in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis","volume":"131","author":"Chiricozzi","year":"2011","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1016\/j.intimp.2026.116936_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1032","article-title":"Emerging role of I\u03baB\u03b6 in inflammation: Emphasis on psoriasis","volume":"12","author":"Gautam","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.intimp.2026.116936_bb0100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cytogfr.2016.01.002","article-title":"S100A7: A rAMPing up AMP molecule in psoriasis","volume":"32","author":"D\u2019Amico","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.intimp.2026.116936_bb0105","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1080\/08820139.2024.2395852","article-title":"Correlation and Clinical Significance of HBD-2 and CXCL-1\/2 Levels at Skin Lesions with Psoriasis Vulgaris Severity","volume":"53","author":"Lin","year":"2024","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.intimp.2026.116936_bb0110","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jaad.2020.10.094","article-title":"CCL20 in psoriasis: A potential biomarker of disease severity, inflammation, and impaired vascular health","volume":"84","author":"Elnabawi","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.intimp.2026.116936_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0625.1995.tb00215.x","article-title":"Cell cycle regulators in the keratinocyte (cyclin-cdk)","volume":"4","author":"Inohara","year":"1995","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.intimp.2026.116936_bb0120","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/j.1460-2075.1992.tb05135.x","article-title":"Cyclin A is required at two points in the human cell cycle","volume":"11","author":"Pagano","year":"1992","journal-title":"EMBO J."},{"key":"10.1016\/j.intimp.2026.116936_bb0125","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.cyto.2014.12.014","article-title":"Cytokines in psoriasis","volume":"73","author":"Baliwag","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2026.116936_bb0130","doi-asserted-by":"crossref","first-page":"1191645","DOI":"10.3389\/fimmu.2023.1191645","article-title":"Pathogenic role of S100 proteins in psoriasis","volume":"14","author":"Liang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116936_bb0135","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.it.2012.11.005","article-title":"The IL-23\/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses","volume":"34","author":"Lowes","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2026.116936_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.153054","article-title":"PSORI-CM02 ameliorates psoriasis in vivo and in vitro by inducing autophagy via inhibition of the PI3K\/Akt\/mTOR pathway","volume":"64","author":"Yue","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.intimp.2026.116936_bb0145","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jid.2019.01.006","article-title":"Imiquimod-induced psoriasis in mice depends on the IL-17 signaling of keratinocytes","volume":"139","author":"Moos","year":"2019","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1016\/j.intimp.2026.116936_bb0150","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-2133.2012.11099.x","article-title":"Psoriasis: rationale for targeting interleukini17","volume":"167","author":"Girolomoni","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.intimp.2026.116936_bb0155","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1084\/jem.194.10.1541","article-title":"CC chemokine receptor (CCR) 4 and the CCR10 ligand cutaneous T cell\u2013attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin","volume":"194","author":"Reiss","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2026.116936_bb0160","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nrrheum.2010.157","article-title":"Psoriasis: what we have learned from mouse models","volume":"6","author":"Wagner","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2026.116936_bb0165","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5906539","article-title":"Effects of wannachawee recipe with antipsoriatic activity on suppressing inflammatory cytokine production in hacat human keratinocytes","volume":"2017","author":"Na Takuathung","year":"2017","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"10.1016\/j.intimp.2026.116936_bb0170","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.it.2004.03.006","article-title":"Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and \u2018Type 1\u2019inflammatory gene expression","volume":"25","author":"Lew","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2026.116936_bb0175","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.0022-202X.2005.23735.x","article-title":"Differential expression of phosphorylated NF-\u03baB\/RelA in normal and psoriatic epidermis and downregulation of NF-\u03baB in response to treatment with etanercept","volume":"124","author":"Lizzul","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2026.116936_bb0180","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.immuni.2007.05.024","article-title":"Crosstalk between keratinocytes and adaptive immune cells in an I\u03baB\u03b1 protein-mediated inflammatory disease of the skin","volume":"27","author":"Rebholz","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.116936_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2021.11.004","article-title":"NF-\u03baB1 contributes to imiquimod-induced psoriasis-like skin inflammation by inducing V\u03b34+ V\u03b44+ \u03b3\u03b4T17 cells","volume":"142","author":"Suzuki","year":"2022","journal-title":"J. Invest. Dermatol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926007824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926007824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:34:11Z","timestamp":1791995651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926007824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":37,"alternative-id":["S1567576926007824"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116936","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological inhibition of TXNRD1 attenuates psoriasis-like dermatitis by suppressing keratinocyte proliferation and NF-\u03baB signaling","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116936","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116936"}}